STAAR Surgical pushes for all-cash merger with Alcon

* STAAR Surgical Company (NASDAQ:STAA [https://seekingalpha.com/symbol/STAA]) said in a presentation today that its $28.00 per share all-cash merger with Alcon provides its stockholders compelling, certain, cash value at a significant premium across multiple measures.
* It represents a 51% premium to STAAR’s closing stock price on August 4, 2025.
* STAAR’s second largest active stockholder, Soleus Capital Master is supportive of the merger and intends to vote in favor absent a material change in circumstances.
* “If the Alcon merger does not move forward, we believe STAAR’s valuation will fall substantially, exposing stockholders to significant risk. The day prior to the announcement of the Alcon merger, STAAR’s stock closed at $18.49 per share following a more than 50% stock price decline in the prior year," Stephen Farrell, CEO of STAAR, said,
* STAA is +0.299065% to $26.83
* Source: Press Release [https://seekingalpha.com/pr/20245705-staar-surgical-publishes-presentation-highlighting-compelling-certain-cash-value-offered-by]

MORE ON STAAR SURGICAL

* STAAR Surgical: Takeover Offer Comes At A Significant Premium [https://seekingalpha.com/article/4808674-staar-surgical-takeover-offer-comes-at-a-significant-premium]
* Staar Surgical urges shareholders to back Alcon merger as “window shop” period ends [https://seekingalpha.com/news/4496953-major-shareholder-yunqi-capital-to-vote-against-staar-surgical-s-proposed-sale-to-alcon]
* STAAR Surgical's largest holder to vote against Alcon bid [https://seekingalpha.com/news/4491272-staar-surgical-largest-holder-oppose-alcon-bid]